A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy of PCSK-9 Inhibitors in Delaying the Progression of Calcified Aortic Valve Disease

NCT06996223 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

316

Enrollment

OTHER

Sponsor class

Conditions

Aortic Stenosis
PCSK9 Inhibitor
Calcified Aortic Valve Disease

Interventions

DRUG: The Group A received PCSK9 inhibitor plus statin therapy

Sponsor

Nanfang Hospital, Southern Medical University